Tempus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
28 Agosto 2024 - 2:30PM
Business Wire
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the
adoption of AI to advance precision medicine and patient care, will
participate in the Morgan Stanley 22nd Annual Global Healthcare
Conference on Wednesday, September 4th, held in New York, NY.
Tempus Founder and CEO, Eric Lefkofsky, will speak in a fireside
discussion at the conference on Wednesday, September 4, 2024 at
8:30 a.m. ET.
About Tempus
Tempus is a technology company advancing precision medicine
through the practical application of artificial intelligence in
healthcare. With one of the world’s largest libraries of multimodal
data, and an operating system to make that data accessible and
useful, Tempus provides AI-enabled precision medicine solutions to
physicians to deliver personalized patient care and in parallel
facilitates discovery, development and delivery of optimal
therapeutics. The goal is for each patient to benefit from the
treatment of others who came before by providing physicians with
tools that learn as the company gathers more data. For more
information, visit tempus.com.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended (the “Securities Act”), and Section 21E of the Securities
Exchange Act of 1934, as amended, about Tempus and Tempus’ industry
that involve substantial risks and uncertainties. All statements
other than statements of historical facts contained in this press
release are forward-looking statements, including, but not limited
to, statements regarding Tempus’ and its employee’s potential
future speaking engagements. In some cases, you can identify
forward-looking statements because they contain words such as
“anticipate,” “believe,” “contemplate,” “continue,” “could,”
“estimate,” “expect,” “going to,” “intend,” “may,” “plan,”
“potential,” “predict,” “project,” “should,” “target,” “will,” or
“would” or the negative of these words or other similar terms or
expressions. Tempus cautions you that the foregoing may not include
all of the forward-looking statements made in this press
release.
You should not rely on forward-looking statements as predictions
of future events. Tempus has based the forward-looking statements
contained in this press release primarily on its current
expectations and projections about future events and trends that it
believes may affect Tempus’ business, financial condition, results
of operations and prospects. These forward-looking statements are
subject to risks and uncertainties related to: Tempus’ financial
performance; the ability to attract and retain customers and
partners; managing Tempus’ growth and future expenses; competition
and new market entrants; compliance with new laws, regulations and
executive actions, including any evolving regulations in the
artificial intelligence space; the ability to maintain, protect and
enhance Tempus’ intellectual property; the ability to attract and
retain qualified team members and key personnel; the ability to
repay or refinance outstanding debt, or to access additional
financing; future acquisitions, divestitures or investments; the
potential adverse impact of climate change, natural disasters,
health epidemics, macroeconomic conditions, and war or other armed
conflict, as well as risks, uncertainties, and other factors
described in the section titled “Risk Factors” in Tempus’ Quarterly
Report on Form 10-Q for the quarter ended June 30, 2024 filed with
the Securities and Exchange Commission (“SEC”) as well as in other
filings Tempus may make with the SEC in the future. In addition,
any forward-looking statements contained in this press release are
based on assumptions that Tempus believes to be reasonable as of
this date. Tempus undertakes no obligation to update any
forward-looking statements to reflect events or circumstances after
the date of this press release or to reflect new information or the
occurrence of unanticipated events, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240828801131/en/
Tempus Investor Relations Elizabeth Krutoholow
Elizabeth.krutoholow@tempus.com
Grafico Azioni Tempus AI (NASDAQ:TEM)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Tempus AI (NASDAQ:TEM)
Storico
Da Gen 2024 a Gen 2025